| PEC0747 | Walk the talk: Engaging community in the HIV research agenda | E-poster | C52 |
| PED1016 | Walking a fine line: Understanding the overlap of sex work and young women in South Africa | E-poster | D34 |
| PEF1840 | War on drugs: Opportunities in accessing to harm reduction services for people who use drugs in Mombasa County | E-poster | F40 |
| PED1176 | We are all women: Barriers and facilitators to inclusion of transgender women in HIV treatment and support services designed for cisgender women | E-poster | D46 |
| PEB0233 | Weight change among treatment naive women initiating dolutegravir in the ARIA study | E-poster | B30 |
| PEB0199 | Weight change before and after switching therapy to tenofovir alafenamide (TAF) in virologically suppressed (VS) persons | E-poster | B22 |
| OAB0605 | Weight changes after switching to doravirine/lamivudine/TDF in the DRIVE-SHIFT trial | Oral abstract session with live Q&A | B22 |
| OAB0602 | Weight gain and hyperglycemia during the dolutegravir transition in Africa | Oral abstract session with live Q&A | B21 |
| PEB0197 | Weight gain associated with antiretroviral therapy in HIV-infected individuals is affected by multiple factors | E-poster | B22 |
| OAB0604 | Weight gain before and after switch from TDF to TAF | Oral abstract session with live Q&A | B22 |